Low molecular weight heparin in prevention of perioperative thrombosis - PubMed (original) (raw)
Clinical Trial
Low molecular weight heparin in prevention of perioperative thrombosis
A Leizorovicz et al. BMJ. 1992.
Abstract
Objective: To determine whether prophylactic treatment with low molecular weight heparin reduces the incidence of thrombosis in patients who have had general or orthopaedic surgery.
Design: Meta-analysis of results from 52 randomised, controlled clinical studies (29 in general surgery and 23 in orthopaedic surgery) in which low molecular weight heparin was compared with placebo, dextran, or unfractionated heparin.
Subjects: Patients who had had general or orthopaedic surgery.
Intervention: Once daily injection of a low molecular weight heparin compared with placebo, dextran, or unfractionated heparin.
Main outcome measures: Incidence of deep venous thrombosis, pulmonary embolism, major haemorrhages, and death.
Results: The results confirm that low molecular weight heparins are more efficacious for the prophylactic treatment of deep venous thrombosis than placebo (common odds ratio 0.31, 95% confidence interval 0.22 to 0.43; p < 0.001) and dextran (0.44, 0.30 to 0.65; p < 0.001). The results suggest that low molecular weight heparins are also more efficacious than unfractionated heparin (0.85, 0.74 to 0.97; p = 0.02), with no significant difference in the incidence of major haemorrhages (1.06, 0.93 to 1.20; p = 0.62).
Conclusions: Low molecular weight heparins seem to have a higher benefit to risk ratio than unfractionated heparin in preventing perioperative thrombosis. However, it remains to be shown in a suitably powered clinical trial whether low molecular weight heparin reduces the risk of fatal pulmonary embolism compared with heparin.
Comment in
- Low molecular weight heparin.
Routledge PA, West RR. Routledge PA, et al. BMJ. 1992 Oct 17;305(6859):906. doi: 10.1136/bmj.305.6859.906. BMJ. 1992. PMID: 1333862 Free PMC article. No abstract available.
Similar articles
- Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis.
Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Leizorovicz A, et al. BMJ. 1994 Jul 30;309(6950):299-304. doi: 10.1136/bmj.309.6950.299. BMJ. 1994. PMID: 8086867 Free PMC article. - Prophylaxis of postoperative thromboembolism with low molecular weight heparins.
Jørgensen LN, Wille-Jørgensen P, Hauch O. Jørgensen LN, et al. Br J Surg. 1993 Jun;80(6):689-704. doi: 10.1002/bjs.1800800607. Br J Surg. 1993. PMID: 7687188 Review. - Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
van Den Belt AG, Prins MH, Lensing AW, Castro AA, Clark OA, Atallah AN, Burihan E. van Den Belt AG, et al. Cochrane Database Syst Rev. 2000;(2):CD001100. doi: 10.1002/14651858.CD001100. Cochrane Database Syst Rev. 2000. PMID: 10796593 Updated. Review. - Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD. Leyvraz PF, et al. BMJ. 1991 Sep 7;303(6802):543-8. doi: 10.1136/bmj.303.6802.543. BMJ. 1991. PMID: 1655136 Free PMC article. Clinical Trial.
Cited by
- Outcomes of Open Fronto-Facial Resection for Fungal Osteomyelitis of Frontal Bone.
Mehta R, Rao KN, Nagarkar NM, Sharma A, Kumar B, Karthik P. Mehta R, et al. Rambam Maimonides Med J. 2022 Oct 27;13(4):e0025. doi: 10.5041/RMMJ.10484. Rambam Maimonides Med J. 2022. PMID: 36394502 Free PMC article. - Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel.
Torrente F, Meade S, Benchimol EI, de Ridder L, Croft NM, Kammermeier J, Mack DR, Klomberg RCW, Turner D, Wilson DC, Martín-de-Carpi J, Bronsky J, Amil Dias J, Walker G, van Ommen CH, Powar MP, Burgess N, Irving PM, Samaan MA, Hansen R. Torrente F, et al. J Crohns Colitis. 2022 Nov 1;16(10):1609-1616. doi: 10.1093/ecco-jcc/jjac073. J Crohns Colitis. 2022. PMID: 35608932 Free PMC article. - Thromboprophylaxis across orthopaedic surgery: Bibliometric analysis of the most cited articles.
Sedani A, Yakkanti R, Allegra P, Mattingly L, Aiyer A. Sedani A, et al. J Clin Orthop Trauma. 2021 Jan 23;16:157-167. doi: 10.1016/j.jcot.2020.12.015. eCollection 2021 May. J Clin Orthop Trauma. 2021. PMID: 33717952 Free PMC article. - Summarizing research findings: systematic review and meta-analysis.
Wong L. Wong L. Malays Fam Physician. 2007 Apr 30;2(1):8-12. eCollection 2007. Malays Fam Physician. 2007. PMID: 25606070 Free PMC article. - Alterations in homeostasis after open surgery. A prospective randomized study.
Dedej T, Lamaj E, Marku N, Ostreni V, Bilali S. Dedej T, et al. G Chir. 2013 Jul-Aug;34(7-8):202-9. doi: 10.11138/gchir/2013.34.7.202. G Chir. 2013. PMID: 24091175 Free PMC article. Clinical Trial.
References
- Acta Chir Scand Suppl. 1990;556:42-50 - PubMed
- Thromb Haemost. 1986 Dec 15;56(3):243-6 - PubMed
- Thromb Haemost. 1991 Sep 2;66(3):368-83 - PubMed
- Thromb Res. 1990 Feb 15;57(4):577-84 - PubMed
- JAMA. 1987 Jul 17;258(3):324-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical